ArticleCancer immunology, immunotherapy : CII2025

Identification of SURF4 and RALGAPA1 as promising therapeutic targets in glioblastoma and pan-cancer through integrative multi-omics, CRISPR-Cas9 screening and prognostic meta-analysis.

Fei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.